Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2013 6
2014 4
2015 2
2016 1
2017 1
2018 5
2019 2
2020 5
2021 7
2022 1
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.
Carr BI, Akkiz H, Guerra V, Üsküdar O, Kuran S, Karaoğullarından Ü, Tokmak S, Ballı T, Ülkü A, Akçam T, Delik A, Arslan B, Doran F, Yalçın K, Altntaş E, Özakyol A, Yücesoy M, Bahçeci Hİ, Polat KY, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Demir A, Yilmaz S, Tokat Y. Carr BI, et al. Clin Pract (Lond). 2018;15(Spec Issue):625-634. doi: 10.4172/clinical-practice.1000409. Clin Pract (Lond). 2018. PMID: 29951199 Free PMC article.
HCC with low- and normal-serum alpha-fetoprotein levels.
Carr BI, Akkiz H, Üsküdar O, Yalçın K, Guerra V, Kuran S, Karaoğullarından Ü, Altıntaş E, Özakyol A, Tokmak S, Ballı T, Yücesoy M, Bahçeci Hİ, Ülkü A, Akçam T, Polat KY, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Demir A, Delik A, Arslan B, Doran F, Yilmaz S, Tokat Y. Carr BI, et al. Clin Pract (Lond). 2018;15(1):453-464. doi: 10.4172/clinical-practice.1000393. Clin Pract (Lond). 2018. PMID: 29576865 Free PMC article.
Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV.
Akkiz H, Carr BI, Guerra V, Donghia R, Yalçın K, Karaoğullarından U, Altıntaş E, Özakyol A, Şimşek H, Balaban HY, Balkan A, Uyanıkoğlu A, Ekin N, Delik A. Akkiz H, et al. J Transl Sci. 2021 Jun;7(3):10.15761/jts.1000421. doi: 10.15761/jts.1000421. Epub 2020 Sep 16. J Transl Sci. 2021. PMID: 34457356 Free PMC article.
Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H, Carr BI, Yalçın K K, Guerra V, Kuran S, Altıntaş E, Üsküdar O, Karaoğullarından Ü, Özakyol A, Tokmak S, Yücesoy M, Bahçeci Hİ, Ülkü A, Akçam T, Yalçın Polat K, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Ballı T, Demir A, Arslan B, Doran F. Akkiz H, et al. Oncology. 2018;94(2):116-124. doi: 10.1159/000484564. Epub 2017 Dec 6. Oncology. 2018. PMID: 29207378 Free PMC article.
Reversibility of regorafenib effects in hepatocellular carcinoma cells.
D'Alessandro R, Refolo MG, Lippolis C, Messa C, Cavallini A, Rossi R, Resta L, Di Carlo A, Carr BI. D'Alessandro R, et al. Cancer Chemother Pharmacol. 2013 Oct;72(4):869-77. doi: 10.1007/s00280-013-2269-8. Cancer Chemother Pharmacol. 2013. PMID: 23959464 Free PMC article.
Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics.
Suner A, Carr BI, Akkiz H, Uskudar O, Kuran S, Tokat Y, Tokmak S, Ballı T, Ulku A, AkCam T, Delik A, Arslan B, Doran F, YalCın K, Ekinci N, Yilmaz S, Ozakyol A, Yücesoy M, BahCeci HI, Polat KY, Şimsek H, Ormeci N, Sonsuz A, Demir M, KılıC M, Uygun A, Demir A, Altıntas E, Karakulah G, Temel T, Bektas A. Suner A, et al. J Transl Sci. 2019 Jun;5(3):10.15761/JTS.1000260. doi: 10.15761/JTS.1000260. Epub 2018 Jun 22. J Transl Sci. 2019. PMID: 30662766 Free PMC article.
36 results